Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-201 (atropine sulfate) Safety in Healthy Volunteers
NCT05470881Phase 1Completed
- Sponsor
- Laboratorios Sophia
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atropine in myopia, sponsored by Laboratorios Sophia. Primary endpoints: Number of Unexpected Adverse Events at 21 days and Number of Patients With Photophobia at 16 days. Started Aug 2022; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05470881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470881.